Neutron Reperfusion Catheter
Acute Ischemic Stroke
CommercialActive
Key Facts
About Gravity Medical Technology
Innovative, cost‑effective neurovascular devices expanding global access to life‑saving stroke treatment.
View full company profileTherapeutic Areas
Other Acute Ischemic Stroke Drugs
| Drug | Company | Phase |
|---|---|---|
| Presendin™ (Exenatide) | Invex Therapeutics | Phase 2 |
| Supernova Stent Retriever | Gravity Medical Technology | Commercial |
| AST-004 | Astrocyte Pharmaceuticals | Phase 1/2 |
| scp776 | Silver Creek Pharmaceuticals | Phase 2 |
| VB-001 | VST Bio | Pre-clinical |
| Pulse NanoMED for AIS | Euphrates Vascular | Pre-clinical |
| NeVa NET | Vesalio | Development/Commercial |
| ApTOLL | aptaTargets | Phase 2 |
| ThermoSuit® for Acute Ischemic Stroke | Life Recovery Systems HD | Pivotal Trial (Planned) |
| Pulsante for Ischemic Stroke | Realeve | Research/Clinical Study |
| Glenzocimab (ACT017) | Acticor Biotech | Phase 2/3 |
| eTrieve™ Microcatheter | Magneto Thrombectomy Solutions | Phase 1 |